Clinical Trial Update: AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke [Phase 3]

View source ↗

Summary

This update reports the Phase 3 ARCADIA trial evaluating antithrombotic strategies to prevent recurrent stroke in patients with atrial cardiopathy after a crypt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptogenic Stroke
• Stroke

Snippet

Sponsor: Columbia University | Conditions: Stroke | Phase 3 | Status: TERMINATED | Results posted: 2025-04-09